Press Room

Webinar: ASDs by Spray Drying: Process Development & Scale-Up

Start
Wednesday, March 22, 2023 - 16:00
Location: online
Webinar - ASDs Amorphous Solid Dispersions by Spray Drying | Hovione

This is the second session of a three-part webinar series on Amorphous Solid Dispersions by Spray Drying: From Early Formulation to Commercial Lifecycle Management.

 

Watch On-demand. 

Gated content. Registration is required.

 

Learn more about this webinar series here.

 

Featured Hovione experts in this webinar
Clara Sá Couto - Manager, R&D Oral Drug Product - Process Development Team | Hovione
José Luís Santos, Ph.D. Director, Technology Intensification | Hovione
Clara Sá Couto, Ph.D.
Manager, R&D Oral Drug Product,
Process Development Team
José Luís Santos, Ph.D.
Director, Technology Intensification

 

​​​​Clara Sá Couto and José Luís Santos will describe the best practices to transition ASD formulations developed in the laboratory into a reliable industrial process, based upon proven methodologies for process development and scale-up, guaranteeing lean and material sparing approaches. 
The webinar will cover industry standard QbD principles, mathematical models and process development methodologies that benefit from extensive development and manufacturing experience. Existing lab assets will be presented, including a customized spray dryer that can mimic large scale powder properties. Finally, the speakers will guide you through a model-based methodology to establish a design space, to prepare the process for validation and commercial supply.

 

Your Key Learning Objectives: 

  • Understand what to consider for the process development and scale-up of ASD formulations manufactured by spray drying to gain a robust process for validation and commercial supply;
  • ​Discover how to develop an industrially reliable ASD formulation in the lab based on advanced mathematical model to be able to generate optimized process conditions that guarantee seamless scaling-up;
  • Learn how to leverage previous experience, databases, and mathematical models to improve process development and troubleshooting, and to establish an optimized design space to enable flexible manufacturing strategies.

 

Who Should Attend: 
This webinar is suitable for anyone working in formulation and process development of amorphous solid dispersions, procurement, and outsourcing teams or project managers, who are interested in understanding the end-to-end process for developing and scaling-up an ASD by spray drying.

 

 

Watch On-demand. 

Gated content. Registration is required.

 

Do you have a challenging project needing differentiating technologies and an innovative approach?

Get in touch today

 

 

 

Also in the Press Room

See All

The global inhalation contract development and manufacturing organization (CDMO) market is projected to grow from USD 9.13 billion in 2025 to USD 16.68 billion by 2035, reflecting a compound annual growth rate (CAGR) of 5.7% during the forecast period. This growth is driven by the increasing prevalence of respiratory diseases, advancements in inhalation drug delivery technologies, and the rising demand for outsourced manufacturing services in the pharmaceutical industry. The inhalation CDMO market has emerged as a pivotal segment in the pharmaceutical contract development and manufacturing industry. With a rising demand for inhaled therapies for conditions like asthma, COPD, and cystic fibrosis, companies are increasingly outsourcing drug development and production to specialized partners. Inhalation CDMO services cater to both large pharmaceutical corporations and small biotech firms, offering expertise in formulation, device compatibility, regulatory support, and scale-up manufacturing. This market is gaining traction due to the complexity of inhalation drug delivery, which often requires niche technical capabilities and specialized equipment. Outsourcing to an inhalation CDMO allows drug developers to reduce time-to-market while ensuring quality and compliance with global standards. (...) Top Companies Several players dominate the inhalation CDMO market through technological expertise, global reach, and service portfolio diversity: (...) Hovione – Offers particle engineering and inhalation development, with a focus on dry powder inhalers. (...) These companies are continually investing in facilities, talent, and technology to meet evolving customer needs in the inhalation CDMO market.   Read the full article on Pharmiweb.com        

Press Clipping

Inhalation CDMO Market Growth Analysis & Forecast 2025 to 2035

Jun 25, 2025